248 related articles for article (PubMed ID: 36694226)
21. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model.
Jia Z; Jiao C; Zhao S; Li X; Ren X; Zhang L; Han ZC; Zhang X
Exp Eye Res; 2012 Sep; 102():44-9. PubMed ID: 22800963
[TBL] [Abstract][Full Text] [Related]
22. Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism.
Rozenberg A; Rezk A; Boivin MN; Darlington PJ; Nyirenda M; Li R; Jalili F; Winer R; Artsy EA; Uccelli A; Reese JS; Planchon SM; Cohen JA; Bar-Or A
Stem Cells Transl Med; 2016 Nov; 5(11):1506-1514. PubMed ID: 27400792
[TBL] [Abstract][Full Text] [Related]
23. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
[TBL] [Abstract][Full Text] [Related]
24. Autophagy enhances mesenchymal stem cell-mediated CD4
Cen S; Wang P; Xie Z; Yang R; Li J; Liu Z; Wang S; Wu X; Liu W; Li M; Tang S; Shen H; Wu Y
Stem Cell Res Ther; 2019 Aug; 10(1):265. PubMed ID: 31443687
[TBL] [Abstract][Full Text] [Related]
25. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
Luz-Crawford P; Noël D; Fernandez X; Khoury M; Figueroa F; Carrión F; Jorgensen C; Djouad F
PLoS One; 2012; 7(9):e45272. PubMed ID: 23028899
[TBL] [Abstract][Full Text] [Related]
27. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
[TBL] [Abstract][Full Text] [Related]
28. Adipose derived mesenchymal stem cell exosomes loaded with miR-10a promote the differentiation of Th17 and Treg from naive CD4
Bolandi Z; Mokhberian N; Eftekhary M; Sharifi K; Soudi S; Ghanbarian H; Hashemi SM
Life Sci; 2020 Oct; 259():118218. PubMed ID: 32784057
[TBL] [Abstract][Full Text] [Related]
29. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
30. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
[TBL] [Abstract][Full Text] [Related]
32. IDO and CD40 May Be Key Molecules for Immunomodulatory Capacity of the Primed Tonsil-Derived Mesenchymal Stem Cells.
Lee HJ; Jung H; Kim DK
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071285
[No Abstract] [Full Text] [Related]
33. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal Stem Cell Induced Foxp3(+) Tregs Suppress Effector T Cells and Protect against Retinal Ischemic Injury.
Agrawal M; Rasiah PK; Bajwa A; Rajasingh J; Gangaraju R
Cells; 2021 Nov; 10(11):. PubMed ID: 34831229
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory effects of mesenchymal stromal cells-derived exosome.
Chen W; Huang Y; Han J; Yu L; Li Y; Lu Z; Li H; Liu Z; Shi C; Duan F; Xiao Y
Immunol Res; 2016 Aug; 64(4):831-40. PubMed ID: 27115513
[TBL] [Abstract][Full Text] [Related]
36. IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4
Zhang A; Xiong Y; Xu F; Wang Z; Ma J; Zhao N; Hu T; Yi J; Zhou Y; Luan X
Cell Immunol; 2020 Jun; 352():104113. PubMed ID: 32331794
[TBL] [Abstract][Full Text] [Related]
37. The investigation of immunomodulatory effects of adipose tissue mesenchymal stem cell educated macrophages on the CD4 T cells.
Özdemir RBÖ; Özdemir AT; Sarıboyacı AE; Uysal O; Tuğlu Mİ; Kırmaz C
Immunobiology; 2019 Jul; 224(4):585-594. PubMed ID: 31072631
[TBL] [Abstract][Full Text] [Related]
38. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
[TBL] [Abstract][Full Text] [Related]
39. Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation.
Yoshida S; Miyagawa S; Toyofuku T; Fukushima S; Kawamura T; Kawamura A; Kashiyama N; Nakamura Y; Toda K; Sawa Y
Sci Rep; 2020 Mar; 10(1):4593. PubMed ID: 32165680
[TBL] [Abstract][Full Text] [Related]
40. Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity.
Reading JL; Yang JH; Sabbah S; Skowera A; Knight RR; Pinxteren J; Vaes B; Allsopp T; Ting AE; Busch S; Raber A; Deans R; Tree TI
J Immunol; 2013 May; 190(9):4542-52. PubMed ID: 23547116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
